Botanical species · safety record

Harrisonia abyssinica

The EFSA Compendium of Botanicals holds 9 constituent measurements for Harrisonia abyssinica. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Harrisonia abyssinica Oliv.

9Constituent measurements

0Safety records

5Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Atalantolide	Bark	Solvent extraction	0.8 Milligram/gram	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Chebulagic acid	Bark	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Harrisonin	Bark	Solvent extraction	6.2 Milligram/gram	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Obacunone	Bark	Solvent extraction	15 Milligram/gram	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Pedonin	Bark	Solvent extraction	10 Milligram/gram	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Furan derivatives	Roots and other underground parts	Solvent extraction	—	IR and Raman Spectroscopy	No resolvable identifier
Proanthocyanidins (condensed tannins)	Leaves	Solvent extraction	54.3 Milligram/gram	UV/VIS spectroscopy (photometry)	No resolvable identifier
Tannins	Leaves	Solvent extraction	193.3 Milligram/gram	UV/VIS spectroscopy (photometry)	No resolvable identifier
Triterpene saponins	Unspecified	Solvent extraction	—	—	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Rubanza, Chrispinus D. K., Shem, Martin N., Ichinohe, Toshiyoshi., Fujihara, Tsutomu. Quantification and characterisation of condensed tannin of selected indigenous browse tree species leaves of north-western Tanzania . Journal of food agriculture & environment, 2008, vol. 6, no. 2, p. 145-149.
Kareru, P. G., Keriko, J. M., Gachanja, A. N., Kenji, G. M. Direct detection of triterpenoid saponins in medicinal plants. African Journal of Traditional, Complementary and Alternative Medicines, 2008, p. 56-60.
Rajab, MS., Rugutt, JK., Fronczek, FR., Fischer, NH. Structural revision of harrisonin and 12 beta-acetoxyharrisonin, two limonoids from Harrisonia abyssinica. JOURNAL OF NATURAL PRODUCTS, 1997, vol. 60, no. 8, p. 822-825. DOI
Kiprop, Ambrose Kipchumba., Kiprono, Paul Chepkwony., Rajab, Mohammed Said., Kosgei, Mathew Kipchumba. Limonoids as larvicidal components against mosquito larvae (Aedes aegypti Linn.) . Zeitschrift fur naturforschung section c-a journal of biosciences, 2007, vol. 62, no. 11-12, p. 826-828.
Lee, Won Jeong., Moon, Jae Sun., Kim, Sung In., Kim, Young Tae., Nash, Oyekanmi., Bahn, Yong-Sun., Kim, Sung Uk. Inhibition of the Calcineurin Pathway by Two Tannins, Chebulagic Acid and Chebulanin, Isolated from Harrisonia abyssinica Oliv.. JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2014, vol. 24, no. 10, p. 1377-1381. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature